3D Aesthetics has announced a conference for its new treatment, 3D EMlift, where the brand will also reveal the results of a clinical trial, following a recent study conducted by Dr Abs Settipalli.
The launch will be held on April 24 at 41 Portland Place, London, and hosted by Dr Settipalli (MCHD, BCHD, BSC), Dr Jonquille Chantrey and 3D Aesthetics founder Roy Cowley.
Attendees will learn first-hand about some of the key findings of the trial, explore the evidence-based technology, and see some of the client results achieved with case studies performed by Dr Chantrey.
Guests can expect VIP catering, expert KOL speaker sessions, and live treatment demonstrations, led by industry experts.
With the chance to also network with existing 3D clinics, professionals will gain insights into the opportunity that this results-driven treatment can offer their business by hearing directly from experts already using this technology on their patients.
How does 3D EMlift work?
The 3D EMlift device combines cutting-edge technologies, proven to deliver impressive facial contouring, anti-ageing, and rejuvenation results by lifting and firming the facial muscles and skin simultaneously.
High-intensity electromagnetic energy selectively engages the muscles, enhancing muscle density and quality, restoring, and elevating the support of facial features, while radiofrequency increases the stimulation of collagen production and elastin fibres through dermal heating, resulting in smoother and more youthful-looking skin.
The release of the initial results of the 3D EMlift trial found that:
• 82% felt a boost in confidence
• 82% observed an increase in muscle tone
• 88% reported a younger appearance
• 94% noticed a visible lift
• 94% saw a reduction in wrinkles
• 100% experienced firmer and tighter skin
• 100% would recommend this treatment
Register your interest to attend the 3D EMlift conference here or call the team on 01788 550 440 to secure your place.
This is a sponsored post in association with 3D Aesthetics.